论文部分内容阅读
目的:分析糖尿病伴肺结核患者抗结核治疗痰菌转阴的临床疗效。方法:选取2014年1月—2015年12月间收治的糖尿病伴肺结核患者30例,从影像学特点,临床表现(发热、咳痰、咳嗽、咯血、胸痛、气急),分析糖尿病伴肺结核患者抗结核药物治疗后痰菌转阴的临床疗效。结果:30例糖尿病伴肺结核患者,痰菌阳性患者为27例占90.00%;痰菌阴性患者为3例占10.00%;经抗结核药物治疗1月痰菌转阴患者为10例,治疗2月痰菌转阴患者为8例,治疗3月痰菌转阴患者为7例,对抗结核药物耐药患者为2例且痰菌呈持续阳性以及痰菌阴性患者为3例。结论:对糖尿病伴肺结核患者,需积极控制血糖值基础上加强抗结核药物治疗,以最大程度提高痰菌的转阴,缓解糖尿病伴肺结核患者症状。
Objective: To analyze the clinical curative effect of antituberculosis treatment of sputum bacterium in patients with diabetes mellitus and pulmonary tuberculosis. Methods: From January 2014 to December 2015, 30 patients with diabetes mellitus and pulmonary tuberculosis were enrolled in this study. Patients with diabetes mellitus and pulmonary tuberculosis were analyzed from the imaging features and clinical manifestations (fever, sputum, cough, hemoptysis, chest pain, shortness of breath) Clinical efficacy of sputum bacterium negative after TB drug treatment. Results: In 30 cases of diabetes with pulmonary tuberculosis, 27 cases accounted for 90.00% of sputum positive patients, 3 cases of sputum negative patients accounted for 10.00%, and 10 cases of sputum negative bacterial transfection by anti-tuberculosis drugs in January were treated in February There were 8 cases of sputum negative conversion, 7 cases of sputum negative conversion in 3 months, 2 cases resistant to tuberculosis drug resistance, 3 cases persistent sputum positive and sputum negative. Conclusion: For patients with diabetes mellitus and pulmonary tuberculosis, anti-TB drug therapy should be strengthened on the basis of active control of blood glucose so as to maximize the negative conversion of sputum bacteria and relieve the symptoms of diabetes patients with pulmonary tuberculosis.